Bengaluru, Aug. 14 -- This Pharma Stock, engaged in global contract research, development, and manufacturing for pharmaceuticals and biologics, specializing in drug discovery, process development, and innovative therapeutic platforms, jumped 9 percent after the company reported strong June quarterly results with a 65 percent YoY increase in net profit.

With a market capitalization of Rs. 45,917.24 crores, the share of Anthem Biosciences Limited has reached an intraday high of Rs. 820 per equity share, rising nearly 8.65 percent from its previous day's close price of Rs. 754.70. Since then, the stock has retreated and is currently trading at Rs. 817 per equity share.

Q1 FY26 Result Walkthrough Coming into the quarterly results of Anthem...